Dimensional Fund Advisors LP Capricor Therapeutics, Inc. Transaction History

Dimensional Fund Advisors LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 07, 2024	SELL	$2.71 - $5.08 $25,056 - $46,969	-9,246 Reduced 38.39%	14,839 $72,000
Q2 2023 Aug 09, 2023	SELL	$3.76 - $5.05 $278,661 - $374,265	-74,112 Reduced 75.47%	24,085 $115,000
Q1 2023 May 12, 2023	SELL	$3.78 - $5.03 $245,408 - $326,562	-64,923 Reduced 39.8%	98,197 $414,000
Q3 2022 Nov 10, 2022	BUY	$3.61 - $6.08 $35,038 - $59,012	9,706 Added 6.33%	163,120 $978,000
Q2 2022 Aug 12, 2022	BUY	$2.89 - $4.51 $13,426 - $20,953	4,646 Added 3.12%	153,414 $535,000
Q1 2022 May 13, 2022	BUY	$2.83 - $5.68 $148,889 - $298,830	52,611 Added 54.71%	148,768 $510,000
Q4 2021 Feb 09, 2022	BUY	$2.89 - $4.16 $195,179 - $280,949	67,536 Added 235.97%	96,157 $282,000
Q3 2021 Nov 12, 2021	BUY	$3.8 - $5.23 $108,759 - $149,687	28,621 New	28,621 $115,000

8.18M

1.78M

1.4M

Ticker CAPR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,346,200
Market Cap $354M
Description
Capricor Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of spectrum of diseases and disorders. Its lead candidate, CAP-1002, an allogeneic cardiac-derived cell therapy, which has completed phase III clinical trial for th...

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

Stay updated on Dimensional Fund Advisors LP with notifications on news.